Statistics for Pedmark® reduced the risk of cisplatin-induced ototoxicity in pediatric patients with hepatoblastoma, seen in a Turkish compassionate use treatment protocol
Total visits
| views | |
|---|---|
| Pedmark® reduced the risk of cisplatin-induced ototoxicity in pediatric patients with hepatoblastoma, seen in a Turkish compassionate use treatment protocol | 2 |
Total visits per month
| views | |
|---|---|
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 2 |
| December 2024 | 0 |